✦ LIBER ✦

Preclinical aspects of anti-VEGF agents for the treatment of wet AMD: ranibizumab and bevacizumab

✍ Scribed by Meyer, C H; Holz, F G

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti-VEGF therapy for the treatment of g

✍ Park, Sung Chul; Su, Daniel; Tello, Celso 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 221 KB

Predictive value of VEGF A and VEGFR2 po

✍ Cruz-Gonzalez, Fernando; Cabrillo-Estévez, Lucía; López-Valverde, Gloria; Cieza- 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 264 KB

A systematic review of the efficacy and

✍ Mitchell, Paul 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 259 KB

O-112 A phase I/II study of the anti-VEG

✍ Sandler, Alan B.; Mininberg, Eric; Henderson, Ted; Kim, Edward; Hong, Waun Ki; M 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 182 KB